Kallikrein 14 Antikörper (AA 114-225) (FITC)
Kurzübersicht für Kallikrein 14 Antikörper (AA 114-225) (FITC) (ABIN7157206)
Target
Alle Kallikrein 14 (KLK14) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 114-225
-
Kreuzreaktivität
- Human
-
Aufreinigung
- >95%, Protein G purified
-
Immunogen
- Recombinant Human Kallikrein-14 protein (114-225AA)
-
Isotyp
- IgG
-
-
-
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, pH 7.4 -
Konservierungsmittel
- ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C,-80 °C
-
Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
-
- Kallikrein 14 (KLK14)
-
Andere Bezeichnung
- KLK14
-
Hintergrund
-
Background: Serine-type endopeptidase with a dual trypsin-like and chymotrypsin-like substrate specificity. May activate/inactivate the proteinase-activated receptors F2R, F2RL1 and F2RL3 and other kallikreins including KLK1, KLK3, KLK5 and KLK11. May function in seminal clot liquefaction through direct cleavage of the semenogelin SEMG1 and SEMG2 and activation of KLK3. May function through desmoglein DSG1 cleavage in epidermal desquamation a process by which the most superficial corneocytes are shed from the skin surface. May be involved in several aspects of tumor progression including growth, invasion and angiogenesis.
Aliases: hK14 antibody, Kallikrein 14 antibody, Kallikrein like protein 6 antibody, Kallikrein-14 antibody, Kallikrein-like protein 6 antibody, KLK L6 antibody, KLK-L6 antibody, KLK14 antibody, KLK14_HUMAN antibody
-
UniProt
- Q9P0G3
-
Pathways
- Komplementsystem, Regulation of G-Protein Coupled Receptor Protein Signaling
Target
-